TNF and psoriasis: Recently, the IP-mediated delivery of the TNF-α drug etanercept [48], the ultrasound-mediated delivery of miR-197 [49], and the fractional laser-mediated delivery of small interfering RNA (siRNA) targeting interleukin-6 [50] have all demonstrated promising results against the pathogenesis of psoriasis.